Skip to main content

Alexander (Bo) Cumbo

Equibles does not estimate personal net worth.

Get an email with a short summary when Climb Bio, Inc. publishes a filing, an earnings call transcript or a press release.

Get CLYM alerts

About Alexander (Bo) Cumbo

Alexander (Bo) Cumbo is recorded as Board Member at Climb Bio, Inc. (CLYM) since June 5, 2026. Climb Bio, Inc. reported in an 8-K filed June 8, 2026 that Alexander (Bo) Cumbo was appointed Director, effective June 5, 2026. Climb Bio, Inc. reported in an 8-K filed April 1, 2025 that Alexander (Bo) Cumbo was appointed member of the Board, effective March 28, 2025. Climb Bio, Inc. is classified in the Biotechnology industry within the Healthcare sector. Other leadership on record at Climb Bio, Inc. includes Aoife Brennan (CEO, CFO and Board Member), Aoife Brennan, M.B., Ch.B. (CEO and Board Member), Dr. Stephen Thomas (CEO) and 7 others.

“The stockholders of the Company elected Alexander (Bo) Cumbo and Douglas Williams, Ph.D., to the Company's Board of Directors, each to serve for a three-year term expiring at the 2029 annual meeting of stockholders and until his respective successor has been duly elected and qualified.”
Climb Bio, Inc. Form 8-K, filed June 8, 2026 · Read the filing
“On March 28, 2025 (the "Effective Date"), the Board increased the size of the Board from seven to eight directors and, upon the recommendation of the nominating and corporate governance committee of the Board, elected each of Alexander (Bo) Cumbo and Kimberlee (Kim) Drapkin as members of the Board, effective immediately.”
Climb Bio, Inc. Form 8-K, filed April 1, 2025 · Read the filing

Affiliation history

Company network

Current role

Biotechnology · Healthcare

Board Member

2026-06-05–present

Leadership on record at Climb Bio, Inc.

Recent activity